By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex's third-quarter revenues rose 35 percent year over year with assay sales climbing 70 percent, the company reported after the close of the market on Tuesday.

The company said that total revenues in the quarter came in at $45.6 million for the three months ended Sept. 30, compared to $33.9 million a year ago, outpacing Wall Street estimates of $43.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.